597577-78-1

Basic information

• Product Name: (4R)-4-[[(1,1-Dimethylethoxy)carbonyl]amino]-5-hydroxypentanoic acid ethyl ester
• Synonyms: (4R)-4-[[(1,1-Dimethylethoxy)carbonyl]amino]-5-hydroxypentanoic acid ethyl ester
• CAS NO: 597577-78-1
• Molecular Formula: C12H23NO5
• Molecular Weight: 261.31472
• Mol File: 597577-78-1.mol

Chemical Properties

• Appearance: /
• CAS DataBase Reference: (4R)-4-[[(1,1-Dimethylethoxy)carbonyl]amino]-5-hydroxypentanoic acid ethyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: (4R)-4-[[(1,1-Dimethylethoxy)carbonyl]amino]-5-hydroxypentanoic acid ethyl ester(597577-78-1)
• EPA Substance Registry System: (4R)-4-[[(1,1-Dimethylethoxy)carbonyl]amino]-5-hydroxypentanoic acid ethyl ester(597577-78-1)

Safety Data

• Hazardous Substances Data: 597577-78-1(Hazardous Substances Data)

Usage

Uses

Used in Organic Synthesis:
(4R)-4-[[(1,1-Dimethylethoxy)carbonyl]amino]-5-hydroxypentanoic acid ethyl ester is used as a building block in organic synthesis for its ability to be easily modified to introduce various functional groups. This makes it a valuable intermediate for the creation of complex organic molecules.
Used in Pharmaceutical Research:
In the pharmaceutical industry, (4R)-4-[[(1,1-Dimethylethoxy)carbonyl]amino]-5-hydroxypentanoic acid ethyl ester is used as a versatile precursor for the synthesis of bioactive compounds and pharmaceuticals. Its presence of a hydroxy and amino group allows for the development of new drugs with potential therapeutic applications.
Used to Improve Solubility and Handling:
The ethyl ester group in (4R)-4-[[(1,1-Dimethylethoxy)carbonyl]amino]-5-hydroxypentanoic acid ethyl ester allows for better solubility and handling of the compound in organic solvents, which is advantageous in chemical reactions and purification processes.

Upstream product

• 1355026-74-2 N-Boc-D-glutamic acid γ-ethyl ester 
• 1355026-75-3 C₁₆H₂₄N₂O₈ 

Downstream Products

• 1365177-41-8 C₂₁H₃₀ClNO₅ 
• 1365646-04-3 C₂₄H₃₀N₂O₄S 
• 1365178-52-4 ethyl (4R,5E)-8-(3-chlorophenyl)-4-({[(2-methyl-2-propanyl)oxy]carbonyl}amino)-7-oxo-5-octenoate 
• 1365177-44-1 ethyl (4R,5E,7S)-4-amino-8-(3-chlorophenyl)-7-hydroxy-5-octenoate trifluoroacetate 
• 1365177-48-5 methyl [3-(2-{(2R)-2-[(1E,3S)-4-(3-chlorophenyl)-3-hydroxy-1-buten-1-yl]-5-oxo-1-pyrrolidinyl}ethyl)phenyl]acetate 
• 1027229-90-8 [3-(2-{(2R)-2-[(1E,3S)-4-(3-chlorophenyl)-3-hydroxybut-1-enyl]-5-oxopyrrolidin-1-yl}ethyl)phenyl]acetic acid 

Relevant articles and documents

Discovery of a novel EP2/EP4 dual agonist with high subtype-selectivity

A series of γ-lactam prostaglandin E1 analogs bearing a 16-phenyl moiety in the ω-chain and aryl moiety in the α-chain were synthesized and biologically evaluated. Among the tested compounds, γ-lactam PGE analog 3 designed as a structural hybrid of 1 and 2 was discovered as the most optimized EP2/EP4 dual agonist with excellent subtype-selectivity (Ki values: mEP2 = 9.3 nM, mEP4 = 0.41 nM). A structure-activity relationship study is presented.

INDOLE COMPOUNDS AS AN INHIBITOR OF CELLULAR NECROSIS

The present invention relates to new indole compounds, pharmaceutically acceptable salts or isomers thereof which are useful for the prevention or treatment of cellular necrosis and necrosis-associated diseases. The present invention also relates to a method and a composition for the prevention or treatment of cellular necrosis and necrosis-associated diseases, comprising said indole compounds as an active ingredient.

INDOLE COMPOUNDS AS AN INHIBITOR OF CELLULAR NECROSIS

The present invention relates to new indole compounds, pharmaceutically acceptable salts or isomers thereof which are useful for the prevention or treatment of cellular necrosis and necrosis-associated diseases. The present invention also relates to a method and a composition for the prevention or treatment of cellular necrosis and necrosis-associated diseases, comprising said indole compounds as an active ingredient.